Price range: $185.00 through $275.00
Selank is a synthetic heptapeptide analog derived from the endogenous immunomodulatory peptide tuftsin. In research environments, Selank is studied for its influence on anxiolytic signaling pathways, neurochemical modulation, and immune–neuro interaction dynamics.
Within controlled laboratory models, Selank is evaluated for its potential impact on GABAergic transmission, BDNF expression, and cytokine balance in neurobehavioral and cognitive research frameworks.
Research Name: Selank
Category: Neuroregulatory peptide
Primary Research Focus: Anxiolytic signaling, cognitive pathway modeling, neuroimmune interaction
Format: Lyophilized powder
Upon reconstitution with an appropriate volume of bacteriostatic water, final concentration will vary depending on total diluent added. Researchers calculate concentration using the standard formula:
Total mg in vial ÷ Total mL added = mg per mL
For U-100 insulin syringes (if utilized in protocol design):
1 mL = 100 units
Units required are determined by dividing the desired mg amount by the final mg/mL concentration.
Preparation methods may vary depending on intranasal or injectable research models.
Selank is studied for its potential influence on:
Neurotransmitter Modulation
GABA receptor pathway signaling
Dopaminergic and serotonergic activity modeling
Synaptic plasticity frameworks
Cognitive & Behavioral Research
Memory consolidation modeling
Stress-response evaluation
Focus and executive-function pathway analysis
Neuroimmune Interaction
Cytokine signaling modulation
Inflammatory marker observation within neural models
Immune–brain communication dynamics
Its mechanism centers around neuromodulation rather than direct sedative activity, distinguishing it from traditional CNS depressant compounds.
Within structured research environments, investigators may observe:
Dose-dependent variables
Behavioral-response shifts
Alertness variability
Mood-related signaling trends
Neurophysiologic observations
Sleep-cycle pattern changes
Cognitive performance fluctuations
Less frequent observations
Mild headache
Nasal irritation (in intranasal protocols)
Temporary fatigue
Monitoring intensity depends on study focus and delivery model.
Administration Frequency: Varies by study design (often daily in cognitive models)
Common Study Duration: 2–8 weeks
Titration Strategy: Incremental adjustments to evaluate neurochemical response
Researchers may exercise caution when combining Selank with other CNS-modulating agents to prevent overlapping pathway effects.
Store lyophilized vial in a cool, dry environment.
Refrigerate after reconstitution.
Maintain sterile laboratory handling procedures at all times.
